INSTITUTIONAL VENTURE MANAGEMENT XVII, LLC
INSTITUTIONAL VENTURE MANAGEMENT XVII, LLC is a Series B and Series C+ fund in the US and Europe writing $10M–$50M checks into AI, Enterprise, Fintech, Healthcare and consumer-internet.
Not currently making new investments (as of September 23, 2026).
- Stages
- Series B, Series C+
- Sectors
- AI, Enterprise, Fintech, Healthcare, consumer-internet
- Check size
- $10M–$50M
- Invests in
- US-wide, Europe
- Actively investing
- No
- Founded
- 1980
- Assets under management
- $7B-$8B
- Website
- ivp.com
Thesis
Institutional Venture Partners XVII, LLC (IVP XVII) is a prominent late-stage venture capital and growth equity firm, part of Institutional Venture Partners (IVP), with a fund size of $1.8 billion. It focuses on investing in rapidly expanding technology companies in the United States and Europe, with a new office in London. IVP XVII looks for the 10-12 fastest growing, most prominent late-stage tech companies each year. The firm's sector interests include enterprise software, consumer internet, financial technology (Fintech), AI, and digital health. IVP XVII's typical investment check size ranges from $10 million to $50 million for initial rounds, with the capacity for substantial follow-on investments. IVP's total AUM is around $7 billion to $8 billion. The firm was founded in 1980 and is headquartered in Menlo Park, California. IVP XVII is a closed fund, with its latest investment recorded in December 2024.
Common questions
Does INSTITUTIONAL VENTURE MANAGEMENT XVII, LLC invest at the Series B stage?
Yes. INSTITUTIONAL VENTURE MANAGEMENT XVII, LLC lists Series B and Series C+ among the stages it invests in.
What check size does INSTITUTIONAL VENTURE MANAGEMENT XVII, LLC write?
INSTITUTIONAL VENTURE MANAGEMENT XVII, LLC writes $10M–$50M checks.
Where does INSTITUTIONAL VENTURE MANAGEMENT XVII, LLC invest?
INSTITUTIONAL VENTURE MANAGEMENT XVII, LLC invests in the US and Europe.